Trium Capital LLP Surmodics Inc Transaction History
Trium Capital LLP
- $791 Million
- Q2 2024
A detailed history of Trium Capital LLP transactions in Surmodics Inc stock. As of the latest transaction made, Trium Capital LLP holds 33,434 shares of SRDX stock, worth $1.3 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
33,434Holding current value
$1.3 Million% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding SRDX
# of Institutions
124Shares Held
13.2MCall Options Held
25.5KPut Options Held
3.4K-
Beryl Capital Management LLC Redondo Beach, CA1.54MShares$59.8 Million25.28% of portfolio
-
Black Rock Inc. New York, NY1.17MShares$45.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.12MShares$43.3 Million0.0% of portfolio
-
Trigran Investments, Inc.1.04MShares$40.5 Million4.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$31.2 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $543M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...